Importantly, validations of the findings in independent cohorts compromising 887 patients with HCC confirmed that high STRN4 expression was significantly associated with poor prognosis (Figure 6D and Supplemental Figure 6B). The gene discussed is STRN4; the disease is hepatocellular carcinoma.